2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1437318474 M.D.
Verify on CMS →

MINGFEI LUO, M.D.

Endocrinology, Diabetes & Metabolism Physician in WOODLAND HILLS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 644 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MINGFEI LUO, M.D. filed 3,855 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in WOODLAND HILLS, California, prescribing 61% generic.

4K
Part D claims, 2023
61%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MINGFEI LUO, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

3,855 Top 9% higher than 91% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MINGFEI LUO, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MINGFEI LUO, M.D.?

Quality data not reported

NPI registry status

Active

Issued 06/05/2008

NPI 1437318474

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

3,855 46% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in California

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among California providers

California providers

Endocrinology, Diabetes & Metabolism Physician share within California

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MINGFEI LUO, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 5601 DE SOTO AVE, WOODLAND HILLS, CA, 91367, with a listed phone of (518) 469-0950. NPI 1437318474 was issued on 06/05/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LUO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,855 prescription claims written by this provider, covering 644 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 39% brand-name and 61% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5601 DE SOTO AVE
WOODLAND HILLS, CA 91367

Provider Details

NPI 1437318474
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 06/05/2008

Hospital and facility affiliations

Facilities where MINGFEI LUO, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
OXNARD, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MINGFEI LUO, M.D.. To verify MINGFEI LUO, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MINGFEI LUO, M.D. — brand share 39.0%
Specialty average (est.)

39% brand-name claims vs 61% generic, on 3,855 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,855
Total Claims
$1.1M
Total Drug Cost
644
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
10,615
Total Day Supply
317,448
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$1.0M
Generic Drug Cost
$52K

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
1.73
Gender Split
61% female / 39% male
Age Distribution
<65: 49, 65-74: 314, 75-84: 233, 85+: 48

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MINGFEI LUO, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
459
Methimazole
193
Ozempic
Semaglutide
186
Humulin N Kwikpen
Insulin Nph Human Isophane
175
Glipizide
165
Jardiance
Empagliflozin
147
Humalog
Insulin Lispro
123
Humalog Kwikpen U-100
Insulin Lispro
108
Atorvastatin Calcium
97
Metformin Hcl
96

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How MINGFEI LUO, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

MINGFEI LUO, M.D.'s 3,855 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as LUO.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MINGFEI LUO, M.D.'s specialty?
MINGFEI LUO, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in WOODLAND HILLS, California. Credentials: M.D..
How much does MINGFEI LUO, M.D. prescribe under Medicare Part D?
In 2023, MINGFEI LUO, M.D. wrote 3,855 Medicare Part D claims totaling $1.1M in drug costs for 644 beneficiaries.
Where is MINGFEI LUO, M.D. located?
MINGFEI LUO, M.D. is located at 5601 DE SOTO AVE, WOODLAND HILLS, CA, 91367. Phone: (518) 469-0950.
What is MINGFEI LUO, M.D.'s NPI number?
MINGFEI LUO, M.D.'s National Provider Identifier (NPI) is 1437318474, issued on 06/05/2008.
Does MINGFEI LUO, M.D. prescribe more brand-name or generic drugs?
MINGFEI LUO, M.D.'s prescribing is 39% brand-name and 61% generic drugs by claim count, with $1.0M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does MINGFEI LUO, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MINGFEI LUO, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Methimazole, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MINGFEI LUO, M.D. accept Medicare?
MINGFEI LUO, M.D. appears in CMS Medicare data with 3,855 Part D claims and 644 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MINGFEI LUO, M.D.'s credentials?
MINGFEI LUO, M.D.'s NPI is 1437318474 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology